Demcizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Demcizumab?
Monoclonal antibody
Source Humanized (from mouse)
Target DLL4
Clinical data
Identifiers
1243262-17-0
None
Chemical data
Formula C6444H10004N1700O2028S52
145.3 kDa

Demcizumab /dɛmˈsɪzʉmæb/ is a humanized monoclonal antibody designed for the treatment of cancer.[1]

This drug was developed by OncoMed Pharmaceuticals.

References[edit]